Kodama T, Kochi Y, Nakai W, et al. Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma. Mol Cancer Ther. 2019;18(9):1555–64.
Article
CAS
PubMed
Google Scholar
Hsieh RW, Go RS, Abeykoon JP, et al. Characteristics of long-term survivors with multiple myeloma: a National Cancer Data Base analysis. Cancer. 2019;125(20):3574–81.
Article
PubMed
Google Scholar
Lai A, Riddell A, Barwick T, Boyd K, Rockall A, Kaiser M, et al. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Eur Radiol. 2020;30(1):320–7.
Article
PubMed
Google Scholar
Zhou C, Chan HP, Dong Q, Couriel DR, Pawarode A, Hadjiiski LM, et al. Quantitative analysis of MR imaging to assess treatment response for patients with multiple myeloma by using dynamic intensity entropy transformation: a preliminary study. Radiology. 2016;278(2):449–57.
Article
PubMed
Google Scholar
Almeida SD, Santinha J, Oliveira F, Ip J, Lisitskaya M, Lourenço J, et al. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI. Cancer Imaging. 2020;20(1):6.
Article
PubMed
PubMed Central
Google Scholar
Wu C, Huang J, Xu WB, Guan YJ, Ling HW, Mi JQ, et al. Discriminating depth of response to therapy in multiple myeloma using whole-body diffusion-weighted MRI with apparent diffusion coefficient: preliminary results from a single-center study. Acad Radiol. 2018;25(7):904–14.
Article
PubMed
Google Scholar
Chen J, Li C, Tian Y, Xiao Q, Deng M, Hu H, et al. Comparison of whole-body DWI and (18)F-FDG PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma. AJR Am J Roentgenol. 2019;213(3):514–23.
Article
PubMed
Google Scholar
Ning Y. Significance of distinguishing 3’-IGH deletion from 5’-IGH deletion in multiple myeloma. Genes Chromosom Cancer. 2021;60(1):54.
Article
CAS
PubMed
Google Scholar
Hamdaoui H, Benlarroubia O, Ait Boujmia OK, Mossafa H, Ouldim K, Belkhayat A, et al. Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients. Mol Genet Genom Med. 2020;8(9):e1363.
CAS
Google Scholar
Saxe D, Seo EJ, Bergeron MB, Han JY. Recent advances in cytogenetic characterization of multiple myeloma. Int J Lab Hematol. 2019;41(1):5–14.
Article
PubMed
Google Scholar
Zhao XQ, Zhao SY, Chen WX, Liu XW, Yan HX, Lou YJ. Correlation between clinical factors and prognosis in newly diagnosed multiple myeloma. J Coll Phys Surg Pak. 2020;30(6):601–5.
Article
Google Scholar
Cheng X, Yu RS, Xu M, Wu XL, Chen CM, Liu WW, et al. The correlation between functional magnetic resonance imaging features and expression of Her-2 in breast cancer. Zhonghua Yi Xue Za Zhi. 2019;99(31):2440–4.
CAS
PubMed
Google Scholar
Pfahler V, D’Anastasi M, Anastasi M, Dürr HR, Schinner R, Ricke J, et al. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus low-dose whole-body CT. Eur J Haematol. 2020;104(5):383–9.
Article
CAS
PubMed
Google Scholar
Offidani M, Boccadoro M, Di Raimondo F, Petrucci MT, Tosi P, Cavo M. Expert panel consensus statement for proper evaluation of first relapse in multiple myeloma. Curr Hematol Malig Rep. 2019;14(3):187–96.
Article
CAS
PubMed
Google Scholar
Kuiper R, Zweegman S, van Duin M, van Vliet MH, van Beers EH, Dumee B, et al. Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial. Blood Adv. 2020;4(24):6298–309.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, et al. NCCN guidelines insights: multiple myeloma, version 1.2020. J Natl Compr Cancer Netw. 2019;17(10):1154–65.
Article
Google Scholar
Razek AA, Ezzat A, Azmy E, Tharwat N. Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma. Radiol Med. 2013;118(5):799–805.
Article
PubMed
Google Scholar
Barnes A, Alonzi R, Blackledge M, Charles-Edwards G, Collins DJ, Cook G, et al. UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer. Br J Radiol. 2018;91(1081):20170577.
Article
PubMed
Google Scholar
Razek AA, Tawfik A, Rahman MA, Teima S. Whole-body diffusion-weighted imaging with background body signal suppression in the detection of osseous and extra-osseous metastases. Pol J Radiol. 2019;84:e453–8.
Article
PubMed
PubMed Central
Google Scholar
Mian H, Mian OS, Rochwerg B, Foley R, Wildes TM. Autologous stem cell transplant in older patients (age ≥ 65) with newly diagnosed multiple myeloma: a systematic review and meta-analysis. J Geriatr Oncol. 2020;11(1):93–9.
Article
PubMed
Google Scholar
Filograna L, Magarelli N, Cellini F, Manfrida S, Leone A, Colosimo C, et al. Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) values for detection of malignant vertebral bone marrow lesions. Eur Rev Med Pharmacol Sci. 2018;22(3):590–7.
CAS
PubMed
Google Scholar
Ou Y, Zöllei L, Retzepi K, Castro V, Bates SV, Pieper S, et al. Using clinically acquired MRI to construct age-specific ADC atlases: quantifying spatiotemporal ADC changes from birth to 6-year-old. Hum Brain Mapp. 2017;38(6):3052–68.
Article
PubMed
PubMed Central
Google Scholar
Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, et al. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma. Hematol Oncol. 2018;36(5):792–800.
Article
CAS
PubMed
Google Scholar
Shouval R, Teper O, Fein JA, Danylesko I, Shem Tov N, Yerushalmi R, et al. LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020;55:1736–43.
Article
CAS
PubMed
Google Scholar
Al Saleh AS, Sidiqi MH, Muchtar E, Buadi FK, Dispenzieri A, Warsame R, et al. Prognostic role of Beta-2 microglobulin in patients with light chain amyloidosis treated with autologous stem cell transplantation. Biol Blood Marrow Transplant. 2020;26(8):1402–5.
Article
CAS
PubMed
Google Scholar
Wu XY, Shi JM, Tao Y, Li Z. Diagnostic value of IGF-I, β2-MG and SF for patients with multiple myeloma and their relationship with clinical staging. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018;26(3):802–6.
PubMed
Google Scholar
Shaikh SP, Irfan SM, Sheikh SS. Disease staging according to international scoring system in newly diagnosed patients with multiple myeloma. Pak J Med Sci. 2019;35(1):90–4.
PubMed
PubMed Central
Google Scholar
Ozaki S, Handa H, Saitoh T, Murakami H, Itagaki M, Asaoku H, et al. Evaluation of the revised international staging system (R-ISS) in Japanese patients with multiple myeloma. Ann Hematol. 2019;98(7):1703–11.
Article
PubMed
Google Scholar
Soekojo CY, Wang GM, Chen Y, Casan J, Wolyncewicz G, Lin A, et al. Role of conventional karyotyping in multiple myeloma in the era of modern treatment and FISH analysis. Clin Lymphoma Myeloma Leuk. 2019;19(8):e470–7.
Article
PubMed
Google Scholar
Byun JM, Kim D, Shin DY, Kim I, Koh Y, Yoon SS. Combination of genetic aberration with international staging system classification for stratification of Asian multiple myeloma patients undergoing autologous stem cell transplantation. Vivo. 2019;33(2):611–9.
Article
CAS
Google Scholar
Abdel Razek AA, Elkhamary S, Al-Mesfer S, Alkatan HM. Correlation of apparent diffusion coefficient at 3T with prognostic parameters of retinoblastoma. AJNR Am J Neuroradiol. 2012;33(5):944–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abdel Razek AA, Kamal E. Nasopharyngeal carcinoma: correlation of apparent diffusion coefficient value with prognostic parameters. Radiol Med. 2013;118(4):534–9.
Article
PubMed
Google Scholar
Razek AA, Nada N. Correlation of choline/creatine and apparent diffusion coefficient values with the prognostic parameters of head and neck squamous cell carcinoma. NMR Biomed. 2016;29(4):483–9.
Article
PubMed
CAS
Google Scholar
Wang Y, Wu Y, Xu Z, Zhou H, Chen Y, Zhan R. Cytogenetic abnormalities in patients with newly diagnosed multiple myeloma as a secondary primary malignancy: a retrospective study. Hematology. 2020;25(1):176–80.
Article
CAS
PubMed
Google Scholar
Cui Y, Liu Y, Wang D, Liu Y, Liu L, Fang B. Comparative analysis of miRNA expression profiles of multiple myeloma with 1q21 gains and normal FISH. Acta Haematol. 2018;139(2):96–100.
Article
CAS
PubMed
Google Scholar
Chatonnet F, Pignarre A, Sérandour AA, Caron G, Avner S, Robert N, et al. The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation. Haematologica. 2020;105(3):774–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tsuyama N, Abe Y, Yanagi A, Yanai Y, Sugai M, Katafuchi A, et al. Induction of t(11;14) IgH enhancer/promoter-cyclin D1 gene translocation using CRISPR/Cas9. Oncol Lett. 2019;18(1):275–82.
CAS
PubMed
PubMed Central
Google Scholar
Li F, Zhai YP, Lai T, Zhao Q, Zhang H, Tang YM, et al. MB4-2/MB4-3 transcripts of IGH-MMSET fusion gene in t(4;14)pos multiple myeloma indicate poor prognosis. Oncotarget. 2017;8(31):51608–20.
Article
PubMed
PubMed Central
Google Scholar
Yuan C, Jin F, Guo X, Zhao S, Li W, Guo H. Correlation analysis of breast cancer DWI combined with DCE-MRI imaging features with molecular subtypes and prognostic factors. J Med Syst. 2019;43(4):83.
Article
PubMed
Google Scholar
Ekert K, Hinterleitner C, Baumgartner K, Fritz J, Horger M. Extended texture analysis of non-enhanced whole-body MRI image data for response assessment in multiple myeloma patients undergoing systemic therapy. Cancers (Basel). 2020;12(3):761.
Article
CAS
Google Scholar
Takasu M, Kondo S, Akiyama Y, Takahashi Y, Maeda S, Baba Y, et al. Assessment of early treatment response on MRI in multiple myeloma: comparative study of whole-body diffusion-weighted and lumbar spinal MRI. PLoS ONE. 2020;15(2):e0229607.
Article
CAS
PubMed
PubMed Central
Google Scholar
Park HY, Kim KW, Yoon MA, Lee MH, Chae EJ, Lee JH, et al. Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response. Cancer Imaging. 2020;20(1):14.
Article
PubMed
PubMed Central
Google Scholar
Zhang Y, Xiong X, Fu Z, Dai H, Yao F, Liu D, et al. Whole-body diffusion-weighted MRI for evaluation of response in multiple myeloma patients following bortezomib-based therapy: a large single-center cohort study. Eur J Radiol. 2019;120:108695.
Article
PubMed
Google Scholar